Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Perioperative scripts for migraine abortive drugs linked with fewer pain readmissions
Key clinical point: Patients with migraine who undergo surgery often need to use a migraine abortive drug perioperatively.
Major finding: Adjusted 30-day hospital readmissions for pain were 36% lower in patients prescribed a migraine abortive agent perioperatively.
Study details: Review of observational data from 21,932 U.S. migraine patients who underwent surgery.
Disclosures: Dr. Platzbecker had no commercial disclosures.
Citation:
REPORTING FROM AHS 2019